The association between atopic dermatitis and rosacea: a comprehensive review from comorbidities to pathogenic mechanisms - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring the Link Between Atopic Dermatitis and Rosacea: An In-Depth Review of Comorbidities and Underlying Mechanisms

  • By

  • Yuewei Zeng

  • Yanyan Feng

  • June 5, 2026

Share

Objective:

To critically evaluate whether the observed convergences between atopic dermatitis (AD) and rosacea represent true mechanistic overlap or parallel but independent responses.

Key Findings:
  • Both AD and rosacea share an upstream innate immune activation platform involving TLR2/TLR4 signaling, NLRP3 inflammasome activation, mast cell degranulation, and neurovascular dysregulation.
  • AD is characterized by Th2/ILC2 skewing and IgE sensitization, while rosacea is dominated by Th1/Th17 involvement and LL-37 overproduction.
  • Dupilumab-induced rosacea-like dermatitis suggests competition between the immune polarization states of AD and rosacea.
Interpretation:

The duality of immune responses in AD and rosacea challenges simplistic models of mechanistic overlap.

Limitations:
  • No formal risk-of-bias assessment was performed due to the narrative nature of the review.
  • The review may not encompass all relevant studies published after April 2026, which could affect the comprehensiveness of the findings.
Conclusion:

Future research should utilize multi-omics approaches and prospective comorbidity cohorts to clarify causal pathways.

Original Source(s)

The association between atopic dermatitis and rosacea: a comprehensive review from comorbidities to pathogenic mechanisms

  • by Yuewei Zeng, Yanyan Feng

  • June 5, 2026

Related Content

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Side Effects: The Details Hiding in Plain Sight

Phones in class, a 25-year prescription gone wrong, pickleball's hidden danger, and why your spin class is too loud — four findings hiding in everyday care.